INKEF Capital is a leading European venture capital firm based in Amsterdam that invests in early-stage health and technology companies with transformative potential. As a patient, long-term investor, INKEF supports entrepreneurs building successful international businesses from the earliest stages.
The firm focuses on IT and life sciences companies with innovative technologies, having funded over 40 companies since its founding. INKEF Capital brings institutional backing with a venture mindset, investing primarily at Series A and Series B in companies based in or expanding to the Netherlands.
INKEF Capital combines deep domain expertise in healthtech, deep tech, and life sciences with strategic guidance and a robust network of industry leaders, research institutions, and corporate partners across Europe.
Amsterdam, Netherlands
"Patient, long-term investors backing transformative health and technology companies — from Amsterdam to the world."
Apply to the Apex Startup Discovery Program
Aligned with INKEF Capital's investment focus. Precondition: You must be an Apex Participant to submit. Registration is complimentary and includes 2 Golden Ads. This project is part of Apex Master Expos.
Apex Ecosystem with Golden Ads
"Who I Am · What I Want"
Complimentary for Apex Participants. Become an Apex Participant at myapex.me — registration is complimentary and includes 2 Golden Ads. Part of Apex Master Expos.
Apex is a living ecosystem — one of its kind. A decentralized, member-owned global business platform across 80+ countries where preferred venture partners such as INKEF Capital can explore early-stage innovation quietly and selectively, while founders showcase on their MySite and gain clarity on what long-term investors truly seek. No middleman. By members, for members.